2015
DOI: 10.1038/srep15286
|View full text |Cite
|
Sign up to set email alerts
|

Estrogen Secreted by Mesenchymal Stem Cells Necessarily Determines Their Feasibility of Therapeutical Application

Abstract: Mesenchymal stem cells are therapeutically applicable and involved in the development of some types of diseases including estrogen (E2)-related ones. Little is known about E2 secretion by mesenchymal stem cells and its potential influence on their therapeutical applications. Our in vitro experiments showed that BMSCs cultured from C57BL/6J mice secreted E2 in a time-dependent manner. In vivo study identified a significantly increased E2 level in serum after a single administration of BMSCs, and a sustained ele… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(17 citation statements)
references
References 40 publications
0
16
1
Order By: Relevance
“…This is likely mediated by the differential expression of genes in response to injury between the two sexes; with males up-regulating pro-inflammatory pathways [ 52 ]. We postulate that male animals benefited more from female MSC as a consequence of the differential gene expression in response to lung injury between the two sexes [ 52 ], and the potential effect of estradiol (E2) secreted by female MSC on the male recipient [ 53 ]. E2 has been shown to increase the efficacy of male MSC in other models of injury [ 41 , 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…This is likely mediated by the differential expression of genes in response to injury between the two sexes; with males up-regulating pro-inflammatory pathways [ 52 ]. We postulate that male animals benefited more from female MSC as a consequence of the differential gene expression in response to lung injury between the two sexes [ 52 ], and the potential effect of estradiol (E2) secreted by female MSC on the male recipient [ 53 ]. E2 has been shown to increase the efficacy of male MSC in other models of injury [ 41 , 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…To determine the binding of monocrotaline to CaSR in cultured PAECs, immunocytochemical staining was performed, as reported previously . Briefly, the PAECs cultured on coverslips were rinsed with warm PBS 3 times, fixed with 4% paraformaldehyde for 20 minutes at room temperature, and rinsed again with PBS 3 times.…”
Section: Methodsmentioning
confidence: 99%
“…8 To determine the binding of monocrotaline to CaSR in cultured PAECs, immunocytochemical staining was performed, as reported previously. 8,18,20 Briefly, the PAECs cultured on coverslips were rinsed with warm PBS 3 times, fixed with 4% paraformaldehyde for 20 minutes at room temperature, and rinsed again with PBS 3 times. After blocking with 5% BSA in a humidified chamber at room temperature overnight and draining off the blocking buffer, the PAECs were incubated with primary monoclonal antibody against CaSR (1:100 diluted in 0.5% BSA in PBS; ABclonal) in a humidified chamber at 4Ā°C overnight.…”
Section: Western Blot and Immunocytochemical Stainingmentioning
confidence: 99%
“…14 Culture conditions are thought to be the most essential factor affecting IVM efficacy. 20 In this regard, previously, the impact of MSC-conditioned media (MSC-CM) on IVM of normal mice oocytes was demonstrated. 14 Recently, mesenchymal stromal cells (MSCs) have been considered as an ideal candidate in regenerative medicine because of their simple isolation techniques and easy expandability.…”
Section: Introductionmentioning
confidence: 97%
“…[14][15][16] On the other hand, because the efficient maturation and fertilization rate of in vitro matured oocytes is not sufficient, clinical applications of the IVM faces limitations. 20,21 MSCs secrete a variety of cytokines and growth factors, such as insulin-like growth factor-1 (IGF-1), VEGF, EGF, fibroblast growth factor (FGF), interleukin-6, leukemia inhibitory factor (LIF), TGF-Ī², and so on. Consequently, most IVF clinics are looking for more effective solutions to improve the developmental competency of immature oocytes.…”
Section: Introductionmentioning
confidence: 99%